TY  - JOUR
AU  - Wculek, Stefanie K
AU  - Amores-Iniesta, Joaquin
AU  - Conde-Garrosa, Ruth
AU  - Khouili, Sofia C.
AU  - Melero, Ignacio
AU  - Sancho, David
PY  - 2019
DO  - 10.1186/s40425-019-0565-5
SN  - 2051-1426
UR  - http://hdl.handle.net/20.500.12105/7504
AB  - BACKGROUND: The manipulation of dendritic cells (DCs) for cancer vaccination has not reached its full potential, despite the revolution in cancer immunotherapy. DCs are fundamental for CD8+ T cell activation, which relies on cross-presentation of...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Cancer immunotherapy
KW  - Cell-associated antigen
KW  - Conventional dendritic cells
KW  - Cross-presenting dendritic cells
KW  - Immunogenic cell death
KW  - Vaccination
KW  - cDC1
TI  - Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
TY  - journal article
ER  -